
Pamica
Kronobränneriet, Halmstad, Halland, 302 42, Sweden
Overview
Pamica AB adds with its wide network of industrial skills and business skills through active ownership in the work of the board and various types of projects. This creates value for shareholders and investors through investment in unlisted, financially prosperous companies. The entrepreneurs that are linked to Pamica all have a proven background in investment or business people in leading positions in relevant industries as well as industries.
- Total investments
- 13
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- miDiagnostics
Participated · Series D · Dec 2024
miDiagnostics develops silicon chip–based qPCR diagnostics that deliver miniaturized, rapid, lab-quality tests directly to patients and clinicians. Its platform integrates a nanofluidic processor on a chip with a compact reader to measure a wide array of biomarkers from minimally invasive samples. The company intends to use the funds to accelerate development of a sterility test for batch release and related quality‑control tests for the BioPharma industry using its proprietary qPCR technology. miDiagnostics raised €30M in a Series D round led by Thermo Fisher Scientific, with participation from Alychlo, VMF Invest and Pamica. Founded in 2015, the company emerged from imec’s R&D hub in collaboration with Johns Hopkins University. miDiagnostics is led by CEO Katleen Verleysen and is based in Leuven, Belgium. miDiagnostics develops a next-generation diagnostic platform based on a silicon nanofluidic processor for point-of-care testing. The platform aims to miniaturise and simplify the diagnostics process to reduce costs and enable rapid, comprehensive health analysis. In response to the coronavirus crisis the company adapted R&D toward an ultrafast PCR test for SARS-CoV-2 intended to deliver PCR accuracy with the speed of rapid antigen tests. Field tests have begun, including trials at Brussels Airport, and the company planned a product launch in spring next year. Financially, miDiagnostics signed a €20M loan agreement with the European Investment Bank supported by the European Commission under the InnovFin Infectious Diseases Finance Facility. The funds will be used to scale up processes, accelerate market launch, and support R&D targeting infectious diseases. miDiagnostics develops an ultra-fast point-of-care PCR test that combines lab-quality PCR accuracy with speeds reported to be about 20 times faster than traditional lab PCR machines. The test uses a PCR testcard read by a compact reader and is built on a nanofluidic silicon‑chip diagnostics platform developed by imec and licensed to miDiagnostics in collaboration with Johns Hopkins University. The company is negotiating its first commercial collaborations, finalizing supplier agreements to scale production, and plans pilot programs shortly after summer. miDiagnostics is also discussing commercialization of a rapid PCR‑based breath test for COVID‑19 recently developed by imec, and it intends to develop a broader portfolio of screening, diagnostic and monitoring tests. The firm accelerated its commercial transition after raising €58 million in additional funding, bringing total capital raised since 2015 to €140 million. Management was reinforced with Katleen Verleysen as CEO and Hans Vanderwegen as COO to lead commercial roll‑out and production scaling. miDiagnostics was spun out of imec and is based in Leuven, Belgium; the company was created in 2015. miDiagnostics is a Leuven-based health tech startup developing a silicon-based nanofluidic processor on a chip paired with a compact reader to run clinical biomarker tests from small samples such as fingerprick blood. CEO Nicolas Vergauwe says the company aims to make "diagnostic information as readily accessible as digital information on a smartphone." The proprietary platform, invented by imec and Johns Hopkins University, claims it can measure virtually any biomarker from easily acquired samples. Target use cases highlighted include home monitoring of chronic patients, fast screening for physicians or remote health centers in developing countries, and widespread monitoring during pandemics. The startup has raised €14 million from existing investors plus Dr. Rudi Pauwels and Dr. Ir. Urbain Vandeurzen to speed development and prepare for industrial-scale manufacturing. The funding is intended to accelerate commercialization of remote clinical testing and scale up chip production.
- Monitr
Led · Equity · Jan 2023
Monitr is an Antwerp, Flanders-based startup offering a SaaS "do-it-yourself" automation tool that provides intelligent cash-flow forecasting for SMEs. Its platform promises entrepreneurs month-to-month and yearly cash-position predictions to increase transparency of their books. CEO Pieterjan Van Dam, drawing on his experience as a CFO, founded Monitr after observing that bookkeeping and Excel-based forecasts often give little actionable insight and are time-consuming. The company cites macroeconomic headwinds and a recent salary indexation drive in Flanders as intensifying pressure on small businesses and driving demand for better cash forecasting. Monitr previously raised venture funding in 2021 and is now announcing a second €500,000 injection, mainly from Pamica NV, to support scaling across Belgium and the Netherlands. The article does not include revenue or user metrics or specify the financing instrument.
- CHILI publish
Participated · Equity · Mar 2022
CHILI publish offers a cloud-based Creative Automation platform that lets brands and agencies create, edit and share visual content via secure graphic templates that enforce brand guidelines. Its customers include large agencies and Fortune 500 brands such as Carrefour, Coca-Cola and Mars across retail, FMCG, real estate and automotive. The platform is also embedded by MarTech vendors like Sitecore, 4AllPortal, Akeneo, Horizontal and Pimcore to create new revenue streams and connectors between content platforms. The company has a team of over 75 people and a global ecosystem of integration partners. CHILI publish intends to use recent funding to accelerate solution and community development, attract new talent, and boost go-to-market and sales operations in the United States and Europe. Financially, the company announced a €10m funding round to support these plans. CHILI publish, founded in 2010 and based in Aalst, Belgium, is a SaaS provider of a browser-based editing software suite called CHILI publisher. The product turns original graphic design work into 'Smart Templates' that let visual creators produce graphics for print, social media, online campaigns and packaging while safeguarding brand guidelines. The company says CHILI publisher is adopted worldwide by both major and niche brands across marketing, retail, cosmetics, food & beverage and other verticals. It also integrates with an extensive ecosystem of third-party partners. CHILI publish recently raised €3 million to boost product development and accelerate expansion into the US. CEO Kevin Goeminne said the funding will speed US market outreach and propel the company's solution development roadmap.
- Cashforce
Participated · Series A · Oct 2019
Cashforce provides a cash forecasting and working capital analytics platform focused on automation and data integration. The platform integrates with ERP and TMS systems and uses advanced analytics and machine learning to deliver accurate cash‑flow forecasting. Positioned as a next‑generation treasury solution, it helps finance and treasury departments save time and cash. Clients include Pearson and Staples. The company operates offices in Amsterdam, Ghent, New York, London and Copenhagen, with Zurich and Singapore planned to follow. Led by Executive Chairman Michel Akkermans and CEO Nicolas Christiaen, Cashforce intends to use recent funding to accelerate global growth and expand into new markets. Cashforce provides a smart cash flow management and forecasting platform that connects with any ERP system for large, capital‑intensive, multinational, multi‑bank, multi‑currency, multi‑ERP enterprises (typically with revenues between €100 million and €10 billion). The platform is used by CFOs and finance departments to gain cash visibility and pro-active cash saving insights. Led by CEO Nicolas Christiaen, the company has offices in Herentals (Antwerp East), Belgium, and New York City, and serves customers such as Hyundai and Portucel. Cashforce raised €1m in a Series A funding round led by Volta Ventures with participation from Pamica NV. As part of the round, Volta Ventures and Michel Akkermans joined Cashforce’s board. The company is using the funds to accelerate product development and to drive its commercial rollout in Europe, partnering with banks, private equity firms and financial consultants.
- Yields.io
Participated · Seed · Jan 2018
Yields.io develops an AI platform and automated model monitoring service for the finance sector that identifies risks and errors in firms' model governance and surfaces new business opportunities. The company positions its product to bring transparency to model testing and to empower model validators, model users and managers with a highly scalable, structured solution. CEO Jos Gheerardyn highlighted that model risk became central after events like the credit crisis and the London Whale incident and that current model testing is largely manual. Yields.io aims to help banks meet increased requirements around model governance. With the recent investment it plans to expand international sales and marketing efforts. Founded last year, the company is based in Ghent and maintains an office in New York.
Team
No current team members are available.